Moleculin Biotech (MBRX)
(Delayed Data from NSDQ)
$4.67 USD
-0.09 (-1.89%)
Updated May 13, 2024 03:59 PM ET
After-Market: $4.70 +0.03 (0.64%) 6:54 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/09/2024
Time: -- |
6/2024 | $-2.82 | 0.00% |
Earnings Summary
For their last quarter, Moleculin Biotech (MBRX) reported earnings of -$2.02 per share, beating the Zacks Consensus Estimate of $-3.59 per share. This reflects a positive earnings surprise of 43.73%. Look out for MBRX's next earnings release expected on August 09, 2024. For the next earning release, we expect the company to report earnings of -$2.82 per share, reflecting a year-over-year increase of 6%.
Earnings History
Price & Consensus
Zacks News for MBRX
Moleculin (MBRX) Up 7% on Upbeat Updates From Annamycin Studies
MBRX: What are Zacks experts saying now?
Zacks Private Portfolio Services